Work

ACSS2 modulates endothelial glycolysis in angiogenesis

Year: 2026
Type: article
Abstract: Endothelial cells (ECs) sustain high glycolytic flux and display remarkable metabolic plasticity. Although molecular pathways regulating endothelial glycolysis are well characterized, metabolic mechanisms underlying hypoxia-induced glycolytic activation during angiogenesis remain poorly understood. Here, we show that acetyl-CoA synthetase 2 (ACSS2) serves as a critical metabolic modulator, coupling acetate utilization with glycolytic flux to control EC function and angiogenesis. The high level of ACSS2-mediated acetate-to-acetyl-CoA conversion in angiogenic front ECs sustains acetyl-CoA levels, which are essential for EC proliferation and retinal vascularization. Conversely, endothelial-specific Acss2 deletion disrupts pathological angiogenesis and normalizes tumor vasculature. Mechanistically, ACSS2 maintains hypoxia-inducible factor 1α transcriptional activity and stabilizes glucose transporter 1, thereby preserving glycolysis. Pyruvate dehydrogenase kinase 4 knockdown rescues metabolic and functional defects in ACSS2-deficient ECs, revealing the vital role of acetyl-CoA homeostasis in modulating hypoxic endothelial metabolism. Taken together, these data establish ACSS2 as a pivotal regulator of vascular development and suggest that targeting acetate metabolism may be an effective way to modulate pathological angiogenesis.
Language: English
Subfield: Cancer Research
Open Access status: hybrid
OpenAlex ID: W7236350125
FWCI:
Cites: 45
Cited by:
Related to: 10